Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: J Pediatr Surg Case Rep. 2022 Aug 26;86:102431. doi: 10.1016/j.epsc.2022.102431

Table 1.

Description of all Lynch syndrome patients.

Patients ≤ 18 Years at Lynch Syndrome Diagnosis (n = 23)

Age at Lynch syndrome Diagnosis (years) Range: 6–18
Median: 16 [15,18]*
Sex (M/F) 10 Female (43.4%)
13 Male (56.5%)
Known Lynch syndrome Pathogenic Variant MHL1: 6 (26.1%)
MSH2: 7 (30.4%)
PMS2: 5 (21.7%)
MSH6: 2 (8.7%)
>1 Pathogenic Variant: 3 (13.0%)
Known family history of Lynch syndrome at Diagnosis 21 (91.3%)
Family History of Lynch syndrome related cancers Yes- 19 (82.6%)
No- 2 (8.7%)
Unclear- 2 (8.7%)
Cancer at time of Lynch syndrome Diagnosis 5 (21.7%)

Table 1: Results are expressed as raw counts with percentage of total patients, unless otherwise specified.

*

Median with quartiles [Q1, Q3].